Howard Sams

Howard Sams has a diverse work experience spanning various industries. Howard'smost recent role is as the CEO and Board Member of Health Outlook Inc., where they use advanced statistical and AI techniques to bridge the gap between proteomic datasets and real-world practice. Howard is also a Partner at Emerald BioVentures, where they incubate and builds life sciences companies. Additionally, they are a Member of the Advisory Board at Glassbeam, Inc.

Prior to their current roles, Howard held several positions at Siemens Healthineers, including Global Head of Digital & Computational Pathology and Vice President of Strategy & New Investments - Diagnostic Imaging. Howard also served as a Board Observer at Proscia. Earlier in their career, Howard worked at Roche, where they held various leadership positions, including Vice President of Marketing for Tissue Diagnostics and Vice President of Centralised & Point of Care Global Marketing.

Before joining Roche, Howard worked at Boston Scientific, where they held roles such as Sales & Field Clinical Representative for Cardiac Rhythm Management and Senior Manager of Global Treasury. Howard also worked in various managerial positions at Ingram Micro Commerce & Lifecycle Services and Bankers Conseco Life Insurance Company.

Overall, Howard Sams has a wealth of experience in areas such as healthcare, life sciences, and finance, and has held leadership positions in multiple organizations throughout their career.

Howard Sams completed their Bachelor's degree in Finance at Butler University - Lacy School of Business from 1989 to 1993. Later, they pursued further education and attained an MBA from the University of Notre Dame - Mendoza College of Business between 2003 and 2005.